Filter by
Filters
Filter results

Date

Primary topics

All topics

Types of content

All types

Products

All products

Diseases

All diseases

General Terms

All terms

Institutions & Events

All events and institutions
Apply
Clear all filters
1 results found
Letter |

Open Letter to J&J: Calling for affordable access to critical TB drug bedaquiline

MSF sent an open letter to Johnson & Johnson urging the pharmaceutical corporation to take action so that countries can access an affordable and sustainable supply of the critical drug bedaquiline, used to treat multidrug-resistant ...
Tags Tuberculosis drug-resistant TBtuberculosis bedaquiline WHO pre-qualification The Global Drug FacilityUNITAIDUSAIDWorld Health OrganizationJohnson & Johnson